Developmental neurotoxicity: Do similar phenotypes indicate a common mode of action? A comparison of fetal alcohol syndrome, toluene embryopathy and maternal phenylketonuria

Toxicology Letters

Volumn 127, Issue 1-3, 2002, Pages 197-205

  Costa, L G ^a,b   Guizzetti, M ^a   Burry, M ^a   Oberdoerster, J ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Aventis CropScience   (United States)

Author keywords

Fetal alcohol syndrome; Glial cells; Maternal phenylketonuria; Neuronal death; Toluene embryopathy

Indexed keywords

ALCOHOL; PHENYLALANINE; TERATOGENIC AGENT; TOLUENE;

AMINO ACID METABOLISM; ASTROCYTE; BRAIN MALFORMATION; CELL MATURATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; DEVELOPMENTAL DISORDER; DIET; EMBRYOPATHY; EXPOSURE; FACIES; FETAL ALCOHOL SYNDROME; GENE MUTATION; GENETIC DISORDER; GROWTH RETARDATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MENTAL DEFICIENCY; METABOLITE; MICROCEPHALY; MOLECULAR BIOLOGY; NERVE CELL NECROSIS; NEUROTOXICITY; PHENYLKETONURIA; PREGNANCY; PRIORITY JOURNAL; VALIDATION PROCESS;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ANIMALS; ETHANOL; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; MATERNAL EXPOSURE; NERVOUS SYSTEM DISEASES; NEUROTOXICITY SYNDROMES; PHENOTYPE; PHENYLKETONURIA, MATERNAL; PREGNANCY; TOLUENE; XENOBIOTICS;

EID: 0037186908     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00501-X     Document Type: Article

References (85)

1. Fetal alcohol syndrome is now leading cause of mental retardation
2. Toluene embryopathy: Clinical delineation and developmental follow-up
3. Vulnerable processes of nervous system development: A review of markers and methods
4. Health effects of toluene: A review
5. Ethanol promotes apoptosis in cerebellar granule cells by inhibiting the trophic effect of NMDA
6. Harmonization of cancer and non-cancer risk assessment; Proceedings of a consensus-building workshop
7. Ethanol selectively interferes with the trophic action of NMDA and carbachol on cultured cerebellar granule neurons undergoing apoptosis
8. Trends in fetal alcohol syndrome - United States, 1979-1993
9. Neuropathalogy in fetal alcohol syndrome
10. Phenylalanine metabolites in phenylketonuria
11. Ethanol promotes cell death by inhibition of the insulin-like growth factor 1 receptor
12. Cerebellar atrophy related to chronic exposure to toluene
13. Acute neurobehavioral effects of toluene
14. Neurobehavioral symptoms among workers occupationally exposed to toluene
15. Toluene abuse embryopathy: Longitudinal neurodevelopmental effects of prenatal exposure to toluene in rats
16. Prenatal exposure to toluene results in abnormal neurogenesis and migration in rat somatosensory cortex
17. The effect of high dose toluene on embryonic development in the rat
18. Development of a rat model of toluene-abuse embryopathy
19. The central nervous system and exposure to toluene: A risk characterization
20. Alcohol, astroglia and brain development
21. Glia and fetal alcohol syndrome
22. Inhibition of muscarinic receptor-stimulated glial cell proliferation by ethanol
23. Effects of ethanol on glial cell proliferation: Relevance to fetal alcohol syndrome
24. Maternal phenylketonuria (PKU) - A review
25. Toluene induces changes in the morphology of astroglia and neurons in striatal primary cell cultures
26. Glia: Listening and talking to the synapose
27. Toluene embryopathy: Two new cases
28. Toluene embryopathy
29. Dose-dependent effects of chronic exposure to toluene on neuronal and glial markers proteins in the central nervous system of rats
30. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome
31. Inhalant abuse in pregnancy
32. Recognition of the fetal alcohol syndrome in early infancy
33. An evaluation of the possible neurotoxicity of metabolites of phenylalanine
34. Maternal phenylketonuria: An international study
35. Neuronal loss in hippocampus in rats exposed to toluene
36. Abnormal cerebral cortical neurons in a child with maternal PKU syndrome
37. Multifocal central nervous system damage caused by toluene abuse
38. Outcome of children of alcoholic mothers (study of 105 cases followed to adult ages) and various prophylactic findings
39. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies
40. Maternal phenylketonuria: A metabolic teratogen
41. Maternal phenylketonuria: Magnetic resonance imaging of the brain of offspring
42. Maternal hyperphenylalaninemia fetal effects
43. Phenylacetate and brain dysfunction in experimental phenylketonuria: Synaptic development
44. Health effects of the alkylbenzenes: Toluene
45. Fetal alcohol exposure and temporal vulnerability: Regional differences in cell loss as a function of the timing of binge-like alcohol exposure during brain development
46. Effect of excess phenylacetate diet during pregnancy on fetal brain growth in rats
47. Generation of neurons in the rat dentate gyrus and hippocampus: Effect of prenatal and postnatal treatment with ethanol
48. Numbers of neurons and glia in mature somatosensory cortex: Effects of prenatal exposure to ethanol
49. Maternal phenylketonuria: A continuing problem
50. Astrocytes as targets for CNS effects of organic solvents in vitro
51. Enhanced caspase activity during ethanol-induced apoptosis in rat cerebellar granule cells
52. Effect of phenylalanine and its metabolites on the proliferation and viability of neuronal and astroglial cells: Possible relevance in maternal phenylketonuria
53. Reproductive and developmental toxicity studies of toluene. I. Teratogenicity study of inhalation exposure in pregnant rats
54. Toluene embryopathy: Delineation of the phenotype and comparison with fetal alcohol syndrome
55. Effects of alcohol on the development of glial cells and myelin
56. Long-term follow-up of children with classical phenylketonuria after diet discontinuation: A review
57. Ethanol inhibits insulin-like growth factor 1-mediated signalling and proliferation of C6 rat glioblastoma cells
58. Retarded development of neurons and oligodendroglia in rat forebrain produced by hyperphenylalaninemia results in permanent deficits in myelin despite long recovery periods
59. Defects in metabolism of amino acids
60. Volatile substance abuse: A review of possible long-term neurological, intellectual and psychiataric sequelae
61. Impairment of callosal and corticospinal system function in adolescents with early-treated phenylketonuria: A transcranial magnetic stimulation study
62. Maternal phenylketonuria collaborative study (MPKUCS) offspring. Facial anomalies, malformations, and early neurological sequelae
63. Maternal phenylketonuria syndrome: Congenital heart defects, microcephaly, and developmental outcomes
64. Astrocyte-derived neurotrophic factors
65. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorders
66. Microencephaly and fetal alcohol syndrome: Human and animal studies
67. Importance of diet in maternal phenylketonuria
68. Phenylketonuria metabolites in cerebellum culture morphology
69. Response of glia to alcohol
70. Prenatal alcohol exposure and long-term developmental consequences
71. Syndromes of toluene sniffing in adults
72. Teratogenic effects of alcohol in humans and laboratory animals
73. Fetal alcohol syndrome in adolescents and adults
74. Phenylalanine and phenylacetate adversely affect developing mammalian brain neurons
75. Fetal solvents syndrome
76. Acidic metabolites of phenylalanine in plasma of phenylketonurics
77. Neuropathology of phenylacetate poisoning in rats: An experimental model of phenylketonuria
78. Teratogen update: Toluene
79. Maternal phenylketonuria
80. Correlates of intelligence test results in treated phenylketonuric children